Chronic Fatigue Syndrome Diagnosis and Management
Diagnostic Criteria
- The American College of Physicians recommends that chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) be diagnosed when patients experience profound fatigue lasting ≥6 months with substantial reduction in pre-illness activities, accompanied by postexertional malaise, unrefreshing sleep, and either cognitive impairment or orthostatic intolerance 1
- The diagnosis of ME/CFS requires the presence of profound fatigue of new or definite onset that is not substantially alleviated by rest, postexertional malaise, unrefreshing sleep, cognitive impairment, and orthostatic intolerance, with a duration of ≥6 months and substantial impairment in occupational, educational, social, or personal activities 1
Screening Approach
- The American Academy of Family Physicians recommends screening fatigue severity using a 0-10 numeric rating scale at every clinical encounter, with scores ≥4 requiring comprehensive evaluation including assessment of physical, cognitive, and emotional domains 2
Differential Diagnoses
- The Centers for Disease Control and Prevention recommends systematically ruling out treatable conditions that cause chronic fatigue, including anemia, hypothyroidism, depression and anxiety disorders, sleep disorders, electrolyte disturbances, and chronic infections 2, 3, 4, 5
Management Algorithm
- The Mayo Clinic recommends offering structured cognitive-behavioral therapy (CBT) as the primary intervention, which demonstrates the strongest evidence for improving health function, quality of life, and physical functioning 3, 2, 7
- The American College of Sports Medicine recommends promoting a consistent pattern of activity, rest, and sleep, and starting physical activity at low intensity and gradually increasing based on tolerance 2
- The National Institute of Mental Health recommends considering mindfulness-based interventions, such as mindfulness-based stress reduction and mindfulness-based cognitive therapy, for enhancing quality of life 3, 2, 7
Pharmacological Management
- The American Academy of Neurology recommends against using stimulants, corticosteroids, antivirals, or antibiotics for ME/CFS, as they have no demonstrated benefit 3, 6, 7
- The American Pain Society recommends considering bupropion, SNRIs (duloxetine), and pregabalin for pain management and improved functional status, though evidence is insufficient specifically for ME/CFS fatigue 2, 3, 7
Ongoing Monitoring and Adjustment
- The American College of Physicians recommends reassessing fatigue levels at every visit using the same 0-10 numeric scale to track response, and modifying management strategies based on response and changes in clinical status 2, 7